Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Hydroxychloroquine may help some hair disorders, but results vary.

Sudanese epilepsy patients often experience hair loss from anti-epileptic drugs but continue their medication regardless of cosmetic side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

All four treatments for early rheumatoid arthritis had similar safety profiles.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Midazolam's antiseizure effects are mainly due to synaptic GABA-A receptors, not neurosteroids or extrasynaptic receptors.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Trazodone might help reverse post finasteride syndrome.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Nano selenium and CoQ10 helped reduce blood fat levels and insulin resistance while preventing muscle damage from statin drugs in rats.

Baricitinib helps treat severe hair loss in people over 65.

Long-term sodium valproate treatment for epilepsy generally caused mild and temporary side effects.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

The FDA approved a new Pfizer drug for hair loss in teens.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.